CD40LG and mantle cell lymphoma: Overall, these data demonstrate that response to anti-IgM stimulation, which mimics the BCR engagement in the tumor microenvironment, induces activation of the BCR downstream signaling, which is heterogeneous among MCL patients’ samples.